Medtech M&A 2024: Looking Onward and Upward | LSI USA ‘24

This Panel took place at LSI USA ‘24 Emerging Medtech Summit in Dana Point, California.

Explore the outlook for Medtech M&A in 2024, with forecasts pointing to rising revenues and significant profit growth, signaling a promising future. Despite recent fluctuations, the market's resilience and increased investor focus on growth quality and sustainable models offer a fertile ground for emerging companies, reflecting a vibrant and opportunistic landscape.

The moderator, John Babbit , EY, was joined by:
Greg Banker - Vensana Capital
Chris Eso - Medtronic
Jennifer Fried - Flow Medical
Bennett Blau - Goldman Sachs

Our Next Event → LSI Europe ‘24 in Portugal on September 16th - 20th, 2024

Join us today → https://www.lifesciencemarketresearch...

Follow us on social:
LinkedIn:   / life-science-intelligence  
Twitter:   / lsintelligence  
Instagram:   / lifescienceintelligence  
Facebook:   / lifescienceintelligence  

Subscribe to our YouTube:    / @lifescienceintelligence